Search results
Lichen Planopilaris: Prevalence, Treatments in the US
Medscape· 4 days agoMost patients diagnosed with LPP received at least one type of medication, most commonly...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 2 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...